IDEXX Laboratories Inc (IDXX)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 1,097,128 1,078,353 1,047,898 930,820 898,765 871,429 852,563 932,750 932,028 917,932 863,826 797,821 694,524 625,060 593,006 564,033 552,846 552,562 530,110 511,429
Total assets US$ in thousands 3,259,920 3,086,400 2,870,810 2,808,400 2,746,760 2,640,070 2,607,180 2,592,690 2,437,200 2,385,740 2,412,150 2,327,380 2,294,560 2,047,410 1,960,710 1,886,240 1,832,480 1,751,480 1,724,240 1,680,970
Operating ROA 33.66% 34.94% 36.50% 33.14% 32.72% 33.01% 32.70% 35.98% 38.24% 38.48% 35.81% 34.28% 30.27% 30.53% 30.24% 29.90% 30.17% 31.55% 30.74% 30.42%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $1,097,128K ÷ $3,259,920K
= 33.66%

To analyze Idexx Laboratories, Inc.'s operating return on assets (ROA), we look at the trend over the past eight quarters. The operating ROA has been relatively stable, ranging from 32.70% to 36.50%. This indicates that the company has been able to generate consistent operating profits relative to its total assets.

The highest operating ROA of 36.50% was achieved in Q2 2023, showing the company's efficiency in generating operating income from its assets during that period. The lowest operating ROA of 32.70% was recorded in Q3 2022, indicating slightly lower profitability during that quarter.

Overall, Idexx Laboratories, Inc. has maintained a healthy operating ROA performance, demonstrating effective management of its assets to generate operating profits. This consistent performance suggests the company's operational efficiency and effectiveness in utilizing its assets to generate revenue.


Peer comparison

Dec 31, 2023